Crypto · IPO · Market Intelligence

Clear Signals for Market Momentum

Track IPOs, private companies, and crypto-related market movements in one modern intelligence platform.

Explore Data

sagi habasov

988 POSTS

Exclusive articles:

SKN | Dollar Tree Seeks to Sustain Momentum Following Strong Share Price Recovery

Dollar Tree, Inc. has attracted renewed investor attention after a strong rally pushed shares above $116, representing a gain of more than 21% over...

SKN | Azul S.A.: Brazilian Airline Equity Story Faces Demand Cycles as Capital Markets Reprice Aviation Risk

Azul S.A. is moving into a renewed capital markets focus as aviation equities continue to trade through uneven demand trends, currency volatility, and fuel-cost...

SKN | Baillie Gifford International Concentrated Growth ETF: High-Conviction Global Equity Strategy Enters Competitive Active ETF Market

Baillie Gifford International Concentrated Growth ETF is moving toward its market debut as active ETF issuers continue to expand aggressively into concentrated global equity...

SKN | Wealthfront Nears Earnings as Profitability Transition Takes Center Stage

Wealthfront Approaches a Key Earnings Test Wealthfront Corporation is preparing to report earnings on June 4, an event that could provide investors with important insight...

SKN | Drone Manufacturer Unusual Machines Soars as Investors Anticipate Potential U.S. Policy Tailwinds

Unusual Machines has emerged as one of the most closely watched IPO stocks after shares surged on reports suggesting potential policy support for domestic...

Breaking

SKN | Aehr Test Systems, Inc.: AI Semiconductor Demand Drives Investor Interest in AEHR

Aehr Test Systems, Inc. is drawing increasing investor attention...

SKN | Belite Bio, Inc.: Late-Stage Drug Development Puts Rare Eye Disease Therapy in Focus

Belite Bio, Inc. is an established publicly traded biotechnology...

SKN | Global IPO Pipeline Reopens as Large US Filings Contrast With Limited Western Pricing

Key Points: Large US filings from SB Energy and...

SKN | ADARx Pharmaceuticals Files for $100 Million IPO to Advance siRNA Drug Pipeline

ADARx Targets $100 Million Biotech IPO ADARx Pharmaceuticals, a clinical-stage...
spot_imgspot_img